Synapse - Hematologic Malignancies, Division of

Results (767)

Results of a phase 2 trial of HGS-ETR1 (Agonistic human monoclonal antibody to TRAIL receptor 1) in subjects with relapsed/refractory non-Hodgkin's lymphoma (NHL)

Meeting Abstract

Younes, A.; Vose, J. M.; Zelenetz, A. D.; Smith, M. R.; Burris, H.; Ansell, S.; Klein, J.; Kumm, E.; Czuczman, M.
Blood (2005)

Fulltext@MSK | Save

Phase II study of dose-adjusted EPOCH-R in untreated de novo CD20+ diffuse large B-cell lymphoma (DLBCL)-CALGB 50103

Meeting Abstract

Wilson, W. H.; Porcu, P.; Hurd, D.; Martin, S. E.; Czuczman, M.; Niedzwiecki, D.; Saint Louis, J. D.; Johnson, J. L.; Cheson, B.; Canellos, G. P.; more...
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Combination chemotherapy regimens with pentostatin in patients with chronic lymphocytic leukemia and other low grade lymphoid neoplasms

Meeting Abstract

Weiss, M. A.; Kalaycio, M.; Zelenetz, A. D.; Lamanna, N.
Annals of Oncology (2005)

Fulltext@MSK | Save

Age significantly influences presentation and patterns of care in patients with newly diagnosed diffuse large cell lymphoma (DLCL): Collective data from 5 centers participating in the National Comprehensive Center Network (NCCN) NHL Outcomes Project

Meeting Abstract

Rodriguez, M. A.; Czuczman, M. S.; Friedberg, J. W.; Kho, M. E.; LaCasce, A. S.; Millenson, M.; Auayporn, N.; Niland, J.; ter Veer, A.; Zelenetz, A. D.; more...
Blood (2005)

Fulltext@MSK | Save

Targeting the proteasome pathway with bortezomib in patients with mantle cell (MCL) and follicular lymphoma (FL) produces prolonged progression free survival among responding patients: Results of a multicenter phase II experience

Meeting Abstract

O'connor, O.; Wright, J.; Moskowitz, C.; Straus, D.; Portlock, C.; Hamlin, P.; Neylon, E.; Evans, A.; Winter, J.; Gordon, L.; more...
Annals of Oncology (2005)

Fulltext@MSK | Save

Targeting the microtubule apparatus in indolent and mantle cell lymphoma with the novel epothilone anlog BMS 247550 induces major and durable remissions in very drug resistant disease

Meeting Abstract

O'connor, O.; Straus, D.; Moskowitz, C.; Hamlin, P.; Portlock, C.; Gerecitano, J.; Neylon, E.; Colevas, D.; Zelenetz, A.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Pralatrexate (10-propargyl-10-deazaaminopterin (PRX)), a novel antifolate, effects durable complete remissions (CR) in patients with a diversity of drug resistant T-cell lymphomas with minimal toxicity

Meeting Abstract

O'connor, O.; Hamlin, P. A.; Neylon, E.; Moskowitz, C.; Portlock, C. S.; Straus, D. J.; Noy, A.; Cortelli, B.; Zelenetz, A. D.; Fleisher, M.; more...
Blood (2005)

Fulltext@MSK | Save

Prospective validation of the FLIPI: Baseline distribution and correlates in newly diagnosed follicular lymphoma (FL) patients from the US: First report of The National LymphoCare Study

Meeting Abstract

Link, B. K.; Cerhan, J. R.; Dillon, H.; Farber, C. M.; Feliciano, S.; Friedberg, J. W.; Hainsworth, J.; Steis, R.; Vose, J. M.; Zelenetz, A. D.
Blood (2005)

Fulltext@MSK | Save

Potential impact of pathologic review on therapy in non-Hodgkin's lymphoma (NHL): Analysis from the national comprehensive cancer network (NCCN) NHL outcomes project

Meeting Abstract

LaCasce, A.; Niland, J.; Kho, M. E.; TerVeer, A.; Friedberg, J. W.; Rodriguez, M. A.; Czuczman, M. S.; Millenson, M.; Zelenetz, A. D.; Nademanee, A. P.; more...
Blood (2005)

Fulltext@MSK | Save

Second-line therapy with ICE followed by high dose therapy and autologous stem cell transplantation for relapsed/refractory peripheral T-Cell lymphomas: Minimal benefit when analyzed by intent to treat

Meeting Abstract

Horwitz, S.; Moskowitz, C.; Kewalramani, T.; Hamlin, P.; Straus, D.; O'connor, O.; Noy, A.; Portlock, C.; Nimer, S.; Palomba, M. L.; more...
Blood (2005)

Fulltext@MSK | Save